"Depressive Disorder, Treatment-Resistant/drug therapy"[MAJR] - Search Results

Year	Number of Results
2011	14
2012	35
2013	44
2014	48
2015	59
2016	71
2017	62
2018	68
2019	99
2020	137
2021	170
2022	132
2023	161
2024	156
2025	130

1

Novel drug developmental strategies for treatment-resistant depression.

Borbély É, Simon M, Fuchs E, Wiborg O, Czéh B, Helyes Z. Borbély É, et al. Br J Pharmacol. 2022 Mar;179(6):1146-1186. doi: 10.1111/bph.15753. Epub 2022 Jan 26. Br J Pharmacol. 2022. PMID: 34822719 Free PMC article. Review.

2

Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.

Nuñez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, Veldic M, Seshadri A, Biernacka JM, Frye MA, Wang Z, Singh B. Nuñez NA, et al. J Affect Disord. 2022 Apr 1;302:385-400. doi: 10.1016/j.jad.2021.12.134. Epub 2022 Jan 2. J Affect Disord. 2022. PMID: 34986373 Free PMC article.

3

Treatment-Resistant Depression: Approaches to Treatment.

Kverno KS, Mangano E. Kverno KS, et al. J Psychosoc Nurs Ment Health Serv. 2021 Sep;59(9):7-11. doi: 10.3928/02793695-20210816-01. Epub 2021 Sep 1. J Psychosoc Nurs Ment Health Serv. 2021. PMID: 34459676 Review.

4

Treatment-Resistant Depression in Older Adults.

Steffens DC. Steffens DC. N Engl J Med. 2024 Feb 15;390(7):630-639. doi: 10.1056/NEJMcp2305428. N Engl J Med. 2024. PMID: 38354142 Free PMC article. Review.

5

Pharmacotherapy: Ketamine and Esketamine.

Feeney A, Papakostas GI. Feeney A, et al. Psychiatr Clin North Am. 2023 Jun;46(2):277-290. doi: 10.1016/j.psc.2023.02.003. Epub 2023 Mar 10. Psychiatr Clin North Am. 2023. PMID: 37149345 Review.

6

Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability.

Smith-Apeldoorn SY, Veraart JK, Spijker J, Kamphuis J, Schoevers RA. Smith-Apeldoorn SY, et al. Lancet Psychiatry. 2022 Nov;9(11):907-921. doi: 10.1016/S2215-0366(22)00317-0. Lancet Psychiatry. 2022. PMID: 36244360

7

Ketamine for depression.

Jelen LA, Stone JM. Jelen LA, et al. Int Rev Psychiatry. 2021 May;33(3):207-228. doi: 10.1080/09540261.2020.1854194. Epub 2021 Feb 11. Int Rev Psychiatry. 2021. PMID: 33569971 Review.

8

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis.

Alnefeesi Y, Chen-Li D, Krane E, Jawad MY, Rodrigues NB, Ceban F, Di Vincenzo JD, Meshkat S, Ho RCM, Gill H, Teopiz KM, Cao B, Lee Y, McIntyre RS, Rosenblat JD. Alnefeesi Y, et al. J Psychiatr Res. 2022 Jul;151:693-709. doi: 10.1016/j.jpsychires.2022.04.037. Epub 2022 May 25. J Psychiatr Res. 2022. PMID: 35688035

9

Esketamine for treatment resistant depression.

Swainson J, Thomas RK, Archer S, Chrenek C, MacKay MA, Baker G, Dursun S, Klassen LJ, Chokka P, Demas ML. Swainson J, et al. Expert Rev Neurother. 2019 Oct;19(10):899-911. doi: 10.1080/14737175.2019.1640604. Epub 2019 Jul 16. Expert Rev Neurother. 2019. PMID: 31282772 Review.

10

Novel antidepressant drugs: Beyond monoamine targets.

Gonda X, Dome P, Neill JC, Tarazi FI. Gonda X, et al. CNS Spectr. 2023 Feb;28(1):6-15. doi: 10.1017/S1092852921000791. Epub 2021 Sep 30. CNS Spectr. 2023. PMID: 34588093 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,185 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,185 results

Results by year